Patients must have postoperative predicted carbon monoxide diffusing capability (DLCO) > 35% prior to surgery obtained within 28 days prior to step 2 registration
All patients must have a carbon monoxide diffusing capability test (DLCO) >= 5.5 m/min/mmHg
Diffusing capacity of the lungs for carbon monoxide (DLCO) >= 50%
Carbon monoxide diffusing capacity (DLCO) 40% predicted.
Hemoglobin-adjusted diffusing capacity of carbon monoxide (DLCO) of >= 45%
Pulmonary function: Carbon monoxide diffusing capability (DLCOc) < 40% normal
Diffusing capacity of the lung for carbon monoxide (DLCO) > 40% predicted, corrected for hemoglobin and/or alveolar ventilation
Adjusted (Adj) carbon monoxide diffusing capability (DLCO) > 45% of predicted corrected for hemoglobin
Corrected diffusing capacity of the lungs for carbon monoxide (DLCO) < 35% or receiving supplemental continuous oxygen
Corrected carbon monoxide diffusing capability (DLCOc) >= 50%
Diffusing capacity for carbon monoxide (DLCO) >= 45% predicted corrected for hemoglobin
Diffusing capacity of the lungs for carbon monoxide (DLCO) > 35% predicted
Carbon monoxide diffusing capability (DLCO) >= 40% predicted
Diffusing capacity >= 45% (adjusted for hemoglobin) predicted by pulmonary function testing
Hemoglobin adjusted pulmonary carbon monoxide diffusing capability test (DLCO) >= 50% of predicted
Diffusing capacity of the lungs for carbon monoxide (DLCO) >= 50% of predicted after correction for anemia
Oxygen saturation >= 90% on room air and adjusted diffusing capacity of the lungs for carbon monoxide (DLCO) of at least 40%
Diffusing capacity of the lungs for carbon monoxide (DLCO) (corrected for hemoglobin) > 40%
Diffusing capacity of the lung for carbon monoxide (DLCO) >= 50% predicted after correction for hemoglobin (must be performed in patients with history of smoking or lung disease); DLCO may be omitted in patients without history of pulmonary disease if approved by the study chair
Diffusing capacity of the lung for carbon monoxide (DLCO) < 40% predicted
Diffusing capacity of the lung for carbon monoxide (DLCO) > 50% of the expected value (using USA-ITS-NIH [United States of America National Institutes of Health] equation) when corrected for hemoglobin (Hgb) (DLCO adjustment [Adj.])
Subjects must have adequate lung function to permit surgical resection determined by pre-enrollment pulmonary function tests to include diffusing capacity of the lungs for carbon monoxide (DLCO)
PART 2: Diffusing capacity of the lung for carbon monoxide (DLCO) corrected > 60% normal\r\n* May not be on supplemental oxygen
Diffusing capacity of the lungs for carbon monoxide (DLCO) >= 50% of expected corrected for hemoglobin and/or volume
Corrected diffusing capacity of the lung for carbon monoxide (DLCOcorr) < 40% normal
Corrected diffusing capacity of the lung for carbon monoxide (DLCO) >= 50%
Diffusing capacity of the lungs for carbon monoxide (DLCO) > 50% corrected for hemoglobin
Diffusing capacity of the lung for carbon monoxide (DLCO) (corrected) < 40% will be excluded
Diffusing capacity of the lung for carbon monoxide (DLCO) >= 50% of expected, corrected for hemoglobin
Active infection or other medical condition which would preclude treatment in the opinion of the principal investigator; this would include a corrected diffusing capacity of the lungs for carbon monoxide (DLCO) of < 60% predicted or symptomatic interstitial lung disease
Diffusing capacity of the lung for carbon monoxide (DLCO) >= 50%
Asymptomatic or if symptomatic, diffusing capacity of the lung for carbon monoxide (DLCO) > 50% of predicted (corrected for hemoglobin)
Inadequate performance status/organ function defined by diffusing capacity of the lung for carbon monoxide (DLCO) < 50% (adjusted for hemoglobin [hgb]), cardiac function as defined below, Karnofsky performance status (KPS) < 60%
Hemoglobin-adjusted diffusing capacity of carbon monoxide < 40%
Diffusing capacity of the lung for carbon monoxide (DLCO) >= 50% of predicted corrected for hemoglobin
Diffusing capacity of the lung for carbon monoxide (DLCO) (adjusted for hemoglobin) >= 45% of predicted
Diffusing capacity of the lung for carbon monoxide (DLCO) 40% of predicted or 3 SD below normal
Diffusing lung capacity for carbon monoxide (DLCO) >= 50%
DLCO (diffusing capacity of the lung for carbon monoxide) >= 50% of predicted, corrected for volume and hemoglobin
Pulmonary function (spirometry and corrected diffusing capacity of the lungs for carbon monoxide [DLCO]) >= 50% predicted
Diffusing capacity of the lungs for carbon monoxide (DLCO) > 60% by pulmonary function test
Diffusing capacity of the lung for carbon monoxide (DLCO) > 50% predicted with no symptomatic pulmonary disease
Pulmonary function tests diffusing capacity of the lungs for carbon monoxide (DLCO) (adjusted for hemoglobin) > 50% predicted
Carbon monoxide diffusing capability (DLCO) corrected >= 60% normal (may not be on supplemental oxygen)
> 50% corrected diffusing capacity of the lung for carbon monoxide (DLCO), if presence of pleural effusion due to metastatic disease > 40% corrected DLCO is acceptable (within 28 days of treatment start)
Severe chronic obstructive lung disease, or symptomatic restrictive lung disease, or corrected diffusing capacity of the lungs for carbon monoxide (DLCO) of < 40% of predicted
Carbon monoxide diffusing capacity (DLCO; corrected for hemoglobin [Hgb]) >= 50% of predicted value
Carbon monoxide diffusing capability test (DLCO) (corrected for hemoglobin) >= 50% predicted
Diffusing capacity for carbon monoxide (DLCO) >= 50% of predicted value (corrected to serum hemoglobin)
Diffusing capacity of the lung for carbon monoxide (DLCO) >= 50% of predicted value (corrected for hemoglobin)
Corrected diffusing capacity of the lung for carbon monoxide (DLCO) greater than or equal to 50% on pulmonary function tests
Adequate pulmonary function with diffusing capacity of the lung for carbon monoxide (DLCO) > 50%
Symptomatic chronic obstructive lung disease, symptomatic restrictive lung disease, or corrected diffusing capacity of the lung for carbon monoxide (DLCO) of < 50% of predicted, corrected for hemoglobin
Diffusing capacity of carbon monoxide (DLCO) corrected for hemoglobin > 50%
Diffusing capacity of the lungs for carbon monoxide (DLCO) (corrected for hemoglobin) =< 50%
Corrected diffusing capacity of the lung for carbon monoxide (DLCOc) >= 40% predicted; if DLCO is < 40%, patients will still be considered eligible if deemed safe after a pulmonary evaluation
Diffusing capacity of the lung for carbon monoxide (DLCO) (corrected) > 50% predicted; if the corrected DLCO is not able to be calculated, principal investigator (PI) must be contacted
Pulmonary function tests (PFTs) with diffusing capacity of the lung for carbon monoxide (DLCO) are conditional for subjects at the discretion of the physician; the required minimum standards for those who have PFTs include DLCO of 40%; those with DLCO of 40-49% must have a pulmonologist consult and assist with management
Diffusing capacity of the lung for carbon monoxide (DLCO) (adjusted for hemoglobin) >= 50 % of predicted
Diffusing capacity of the lung for carbon monoxide (DLCO) < 50% corrected for hemoglobin
Asymptomatic or if symptomatic, diffusing capacity of the lung for carbon monoxide (DLCO) > 50% of predicted (corrected for hemoglobin)
Diffusing capacity of the lung for carbon monoxide (DLCO) >= 40% of predicted (corrected for hemoglobin)
Diffusing capacity of the lung for carbon monoxide (DLCO) corrected > 60% normal
Pulmonary function > 50% corrected diffusing capacity of the lungs for carbon monoxide (DLCO)
Diffusing capacity of carbon monoxide >= 50% of predicted
Diffusing capacity of the lung for carbon monoxide (DLCO) (adjusted) > 50%
Patients must also have a resting multi gated acquisition scan (MUGA) (preferred) or echocardiogram (ECHO) and pulmonary function tests (PFTs) with diffusing capacity of the lung for carbon monoxide (DLCO) performed before transplant and found to be acceptable according to the treating institutionâ€™s guidelines; recommended minimum standards include an ejection fraction (EF) greater than 35% and corrected DLCO greater than 35% for this less toxic regimen; if lower than this, single patient exemption may be sought
History of clinically significant pulmonary fibrosis or documented diffusing capacity of the lung for carbon monoxide <50% predicted
Pulmonary: asymptomatic or if symptomatic, diffusing capacity of the lungs for carbon monoxide (DLCO) > 50% of predicted (corrected for hemoglobin)
Carbon monoxide diffusing capacity (DLCO) >= 50% of predicted corrected for hemoglobin
Abnormal lung diffusion capacity (diffusing capacity of the lungs for carbon monoxide [DLCO] < 40% predicted)
Diffusing capacity of the lungs for carbon monoxide (DLCO) <60% of the predicted values
Diffusing capacity of the lungs for carbon monoxide (DLCO) >= 40%
Diffusing capacity of the lung for carbon monoxide (DLCO) >= 50% of expected corrected for hemoglobin
Patient pulmonary function showed that pre-bronchial dilator FEV1 < 25% or diffusing capacity of the lung for carbon monoxide (DLCO) < 25%
Diffusing capacity of the lungs for carbon monoxide (DLCO) >= 45% predicted corrected for hemoglobin; for pediatric patients, if unable to perform pulmonary function, >= 92% oxygen saturation with pulse oximetry
Diffusing capacity of the lung for carbon monoxide (DLCO) > 50% of expected value (hemoglobin [Hb] corrected), obtained within 28 days of enrollment
Diffusing capacity of the lung for carbon monoxide (DLCO) >= 40%; no symptomatic pulmonary disease
Pulmonary function tests (PFTs) with diffusing capacity of the lung for carbon monoxide (DLCO) within 90 days prior to registration
Has a pre-treatment pulmonary function test (PFT) showing an carbon monoxide diffusing capability (DLCO) adjusted for hemoglobin of less than 60%
DLCO (diffusing capacity of the lung for carbon monoxide) (corrected for hemoglobin) >= 50% of predicted
Pulmonary: asymptomatic or if symptomatic, diffusing capacity of the lung for carbon monoxide (DLCO) > 60% of predicted (corrected for hemoglobin)
Diffusing capacity for carbon monoxide (DLCO) adjusted for hemoglobin or forced vital capacity (FVC) > 50% predicted
Diffusing capacity of the lung for carbon monoxide to alveolar volume (DLCO/VA) > 40%
Corrected diffusing capacity of the lungs for carbon monoxide (DLCOcorr) > 40% normal
Diffusing capacity of the lung for carbon monoxide (DLCO) > 40% predicted, corrected for hemoglobin and/or alveolar ventilation
Diffusing capacity of the lungs for carbon monoxide (DLCO) >= 50% of predicted (corrected for hemoglobin)
Diffusing capacity for carbon monoxide (hemoglobin corrected DLCO) < 50% predicted
Diffusing capacity for carbon monoxide (DLCO) < 50% predicted
Carbon monoxide diffusing capability (DLCO) > 60% (hemoglobin adjusted) by pulmonary function test (PFT)s
